This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Rare disease start-up Harmony raises $270mm in early equity funding
09 Oct 2017
Concurrent with procuring an exclusive US license to Bioprojet's narcolepsy candidate pitolisant, Harmony Biosciences LLC (developing rare disease therapeutics) announced it raised $270mm in equity financing (assumed to be its Series A round) from 29 investors, including Valor Equity Partners, Fidelity Management & Research, HBM Healthcare Investments, Vivo Capital, venBio Partners, Novo Holdings, and Nan Fung Life Sciences.
Drug Discovery Tools
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?